BullFrog AI Holdings (BFRGW) Net Cash Flow Growth (1y) (2023 - 2025)
Powered by 
Analysis
BullFrog AI Holdings (BFRGW) Net Cash Flow Growth (1y) (2023 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.66 Bn | 197.67 Bn | 7.24 Bn | 349.49% |
| 2 | Gilead Sciences | 181.20 Bn | 178.03 Bn | 6.22 Bn | -55.11% |
| 3 | Vertex Pharmaceuticals | 132.30 Bn | 124.45 Bn | 2.84 Bn | 172.72% |
| 4 | Regeneron Pharmaceuticals | 82.63 Bn | 74.64 Bn | 3.93 Bn | 53.21% |
| 5 | Argenx Se | 61.60 Bn | 56.41 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.55 Bn | 49.41 Bn | 52.00 Mn | 47.11% |
| 7 | Alnylam Pharmaceuticals | 34.01 Bn | 30.71 Bn | 992.69 Mn | -100.75% |
| 8 | Biogen | 31.26 Bn | 29.97 Bn | 1.96 Bn | -2,371.48% |
| 9 | Roivant Sciences | 29.87 Bn | 29.87 Bn | 1.16 Mn | - |
| 10 | BullFrog AI Holdings | 1.84 Mn | -5.08 Mn | 106,899.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -83.88% |
| Sep 30, 2025 | 64.88% |
| Jun 30, 2025 | 12.41% |
| Mar 31, 2025 | -137.26% |
| Dec 31, 2024 | 197.21% |
| Sep 30, 2024 | 14.25% |
| Jun 30, 2024 | -3,587.39% |
| Mar 31, 2024 | -18.20% |
| Dec 31, 2023 | -8,067.56% |
| Sep 30, 2023 | -717.14% |
| Jun 30, 2023 | -82.06% |
| Mar 31, 2023 | 38,267.45% |